Animal facility virus testing is a systematic health monitoring program that verifies the specific pathogen free (SPF) status of laboratory rodent and rabbit colonies through serological, molecular, and environmental screening. By detecting adventitious viral agents such as murine norovirus, mouse hepatitis virus, and rodent parvoviruses in accordance with GB 14922, GB/T 14926, and FELASA recommendations, accredited third-party laboratories help animal facilities protect research data integrity, safeguard valuable animal strains, and maintain compliance with GLP and institutional quality requirements.
Technical Overview
Animal facility virus testing, also referred to as virological health monitoring, is the core component of any laboratory animal health surveillance program. Most viral infections in laboratory mice, rats, rabbits, and other species are subclinical, producing no visible signs of disease while silently altering immune function, cytokine profiles, organ histology, reproductive performance, and tumor growth kinetics. Routine virological screening is therefore the only reliable way to confirm that animal colonies remain free of adventitious viral agents and that experimental data remain reproducible.
In China, national standards GB 14922.1 and GB 14922.2 define the parasitological and microbiological quality requirements for laboratory animals across different hygiene grades, including conventional, clean, SPF (specific pathogen free), and germ-free categories, while the GB/T 14926 series specifies the standard test methods for each pathogen. Internationally, recommendations published by the Federation of European Laboratory Animal Science Associations (FELASA) and guidance from the American Association for Laboratory Animal Science (AALAS) and the International Council for Laboratory Animal Science (ICLAS) are widely used as the scientific basis for monitoring program design, pathogen exclusion lists, and testing frequency.
Modern facilities increasingly house animals in individually ventilated cage (IVC) systems and barrier rooms. While these technologies dramatically reduce pathogen transmission, they also reduce the exposure of traditional soiled-bedding sentinels to infectious agents. As a result, contemporary monitoring programs combine sentinel serology with direct PCR testing of colony animals and environmental PCR testing of IVC rack exhaust dust, creating a tiered surveillance strategy that balances sensitivity, cost, and animal welfare (refinement and reduction of animal use).
Testing Samples
Serum Samples
Serum is the primary matrix for antibody-based screening. Blood is collected via submandibular, saphenous, tail vein, or retro-orbital puncture for live sampling, or by cardiac puncture at necropsy. Approximately 100 to 300 microliters of blood from a mouse yields sufficient serum for a full viral panel using modern micro-assay formats. Samples should be free of hemolysis, stored at 2 to 8 degrees Celsius for short-term transport, and frozen at minus 20 degrees Celsius or below for longer storage.
Oral, Nasal, and Anal Swabs
Mucosal swabs are collected with sterile swabs and placed in viral transport medium for nucleic acid detection. They are particularly valuable during the acute shedding phase of respiratory and enteric viruses, before antibodies have developed, and are suitable for testing immunodeficient strains such as nude and SCID mice that cannot mount a detectable antibody response.
Fecal Samples and Bedding
Fresh fecal pellets enable direct PCR detection of enterotropic agents, including murine norovirus, enterotropic mouse hepatitis virus, and rotavirus. Soiled bedding collected from multiple cages is either tested directly by PCR or used to expose sentinel animals over a defined contact period, typically four to eight weeks.
Environmental and Exhaust Dust Samples
Swabs taken from IVC rack exhaust plenums, air supply and exhaust filters, cage-changing stations, biosafety cabinets, room surfaces, and rack manifolds have been validated as a highly sensitive, non-animal-based monitoring matrix. Because the IVC airflow continuously concentrates aerosolized fur, dander, and fecal particulates, a single exhaust dust PCR panel can reflect the viral status of all cages connected to a rack.
Tissue and Organ Samples
At necropsy, tissues such as lung, liver, spleen, kidney, mesenteric lymph nodes, cecum, and brain are collected for confirmatory diagnosis, virus isolation, histopathology, and immunohistochemistry when clinical disease, unexplained mortality, or index-positive screening results require etiological investigation.
Testing Items
Testing panels are structured according to the pathogen exclusion lists defined in GB 14922.2 and by international monitoring recommendations, with virus panels customized by species, hygiene grade, and the intended use of the animals, for example breeding stock, oncology models, or immunology research.
Mice
- Murine Norovirus (MNV)
- Mouse Parvovirus (MPV) and Minute Virus of Mice (MVM, including MVMp and MVMi strains)
- Mouse Hepatitis Virus (MHV), both respiratory and enterotropic biotypes
- Sendai Virus (murine parainfluenza virus type 1)
- Pneumonia Virus of Mice (PVM)
- Reovirus Type 3 (Reo-3)
- Theiler's Murine Encephalomyelitis Virus (TMEV, murine encephalomyelitis virus)
- Lymphocytic Choriomeningitis Virus (LCMV)
- Ectromelia Virus (mousepox)
- Mouse Adenovirus (MAdV-1 strain FL and MAdV-2 strain K87)
- Mouse Cytomegalovirus (MCMV)
- Mouse Polyomavirus and Murine Pneumotropic Virus (K virus)
- Epizootic Diarrhea of Infant Mice (EDIM, murine rotavirus)
- Hantavirus (Hantaan and Seoul serotypes)
Rats
- Kilham Rat Virus (KRV), Rat Minute Virus (RMV), Rat Parvovirus (RPV), and Toolan's H-1 Virus
- Rat Coronavirus (RCV) and Sialodacryoadenitis Virus (SDAV)
- Sendai Virus and Pneumonia Virus of Mice
- Reovirus Type 3
- Rat Theilovirus (RTV)
- Rat Adenovirus and Rat Cytomegalovirus (RCMV)
- Hantavirus (Seoul virus)
Rabbits
- Rabbit Hemorrhagic Disease Virus (RHDV), including antigenic variant RHDV2
- Rabbit Coronavirus
- Lapine Rotavirus and Lapine Parvovirus
- Rabbit Oral Papillomavirus
Guinea Pigs and Hamsters
- Guinea Pig Adenovirus and Guinea Pig Cytomegalovirus
- Sendai Virus and Pneumonia Virus of Mice in hamster colonies
- Reovirus Type 3 and Lymphocytic Choriomeningitis Virus
- Hamster Parvovirus and enteric viral agents
Testing Methods
Serological Methods
Serology detects antibodies and therefore indicates historical exposure to a viral agent. It is the backbone of most routine monitoring programs because a single serum sample can be screened against a broad panel of antigens.
- ELISA (enzyme-linked immunosorbent assay): the standard high-throughput primary screening method for most viral antigens.
- IFA (indirect fluorescent antibody test): a confirmatory method following equivocal or positive ELISA results.
- MFIA (multiplex fluorescent immunoassay): bead-based multiplex technology allowing dozens of antibody specificities to be tested simultaneously from a minimal serum volume.
- HI (hemagglutination inhibition): a traditional confirmatory assay for hemagglutinating viruses such as parvoviruses and reoviruses.
- Virus neutralization (NT/SN): a highly specific confirmatory test based on the inhibition of viral cytopathic effect in cell culture.
Molecular Methods
Nucleic acid testing detects the viral agent itself rather than the host immune response, providing earlier detection during the acute phase of infection and reliable results in immunodeficient animals that fail to seroconvert.
- Conventional PCR and RT-PCR for agent detection in swabs, feces, tissues, and environmental swabs.
- Real-time quantitative PCR (qPCR) for sensitive, contamination-controlled quantification of viral loads.
- Multiplex PCR panels covering complete virus lists from pooled or individual samples.
- Sanger or next-generation sequencing for genotyping, outbreak tracing, and confirmatory identification of novel or atypical agents.
Confirmatory and Complementary Methods
For index-positive or clinically ambiguous cases, virus isolation in permissive cell cultures, immunohistochemistry, in situ hybridization, and histopathological examination of target organs provide definitive etiological confirmation. Historically, antibody production tests such as the mouse antibody production (MAP) test were used to screen biological materials, and this principle remains relevant for screening tumors, cell lines, sera, and other biologics before introduction into animal facilities.
Applications
Virus testing services are applied across the entire life cycle of laboratory animal management, from breeding colony maintenance to experimental study support.
- Routine quarterly health monitoring of SPF breeding colonies and research colonies, in line with FELASA monitoring frequency recommendations.
- Certification and periodic verification of barrier facility integrity, including quarantine rooms, production rooms, and experimental units.
- Quarantine screening of incoming animals from commercial vendors or collaborating institutions before release into the main colony.
- Outbreak investigation, source tracing, and evaluation of decontamination effectiveness following a positive finding.
- Health report generation supporting GLP-compliant toxicology and pharmacology studies and regulatory submissions.
- Validation of rederivation procedures such as embryo transfer and hysterectomy derivation used to rescue valuable genetically modified strains.
- Pathogen screening of cell lines, tumor xenografts, serum, and other biological materials prior to animal passage.
- Inter-institutional transfer documentation and import/export health certification for laboratory animals.
FAQ
How frequently should virus testing be performed?
For most SPF rodent facilities, quarterly monitoring is the internationally recommended baseline frequency, with monthly or risk-based intensified sampling for high-value colonies, immunodeficient strains, or facilities with a recent contamination history. Environmental PCR testing of IVC exhaust dust is well suited for interim monitoring between scheduled sentinel bleeds.
Should we rely on sentinels or test colony animals directly?
A hybrid approach is best practice. Soiled-bedding sentinels reliably detect agents transmitted via fecal-oral routes but may miss strictly respiratory or fur-borne agents. Direct PCR testing of representative colony animals, particularly immunodeficient strains, and exhaust dust PCR of IVC racks close this sensitivity gap and reduce total sentinel animal use, supporting the 3Rs principles of replacement, reduction, and refinement.
What does it mean when ELISA is negative but PCR is positive?
This pattern typically indicates an early, acute infection before seroconversion, infection of an immunodeficient host, or localized shedding with limited systemic antibody response. Confirmatory testing on additional samples and follow-up serology two to three weeks later are recommended to establish colony status.
How should samples be shipped to the laboratory?
Serum and swab samples should be transported refrigerated at 2 to 8 degrees Celsius with ice packs for arrival within 48 to 72 hours, or frozen on dry ice for longer transit. Environmental swabs are stable at ambient temperature for short periods but should be kept cool whenever possible. Complete sample metadata, including species, strain, cage or rack identification, and collection date, is essential for correct interpretation.
What actions are required after a positive viral result?
Positive findings should first be confirmed with an independent method, such as PCR confirmation of a serological positive. Confirmed infections typically require immediate quarantine of affected racks, intensified surveillance of adjacent units, notification of affected researchers, risk assessment of ongoing studies, and either depopulation with environmental decontamination or rescue of valuable strains through embryo transfer rederivation, depending on the agent and colony value.